Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial.
about
Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the BrainVascular dysfunction as a target for adjuvant therapy in cerebral malariaPathophysiological Mechanisms in Gaseous Therapies for Severe MalariaInhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malariaIn vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway.Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011-2013.Methemoglobin and nitric oxide therapy in Ugandan children hospitalized for febrile illness: results from a prospective cohort study and randomized double-blind placebo-controlled trial.Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trialDefining Surrogate Endpoints for Clinical Trials in Severe Falciparum MalariaEndothelial activation, haemostasis and thrombosis biomarkers in Ugandan children with severe malaria participating in a clinical trial.Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria.Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan childrenPerformance of point-of-care diagnostics for glucose, lactate, and hemoglobin in the management of severe malaria in a resource-constrained hospital in Uganda.Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier.Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.A better biomarker for cerebral malaria: in the eye of the beheld?*.Inhaled nitric oxide and cognition in pediatric severe malaria: A randomized double-blind placebo controlled trial.Endothelial Activation: The Ang/Tie Axis in Sepsis.
P2860
Q26778543-BDD8D139-EE50-498F-9A36-57E30CB2AB96Q27025436-F16EAB0E-D2F4-4150-8851-DF8B2BC5F806Q28080030-66D5DF1C-5442-4931-8438-BBC9AD0502E8Q28742640-B9E02328-7FA6-498C-821C-566845B29424Q34303004-D55E82B5-82F9-49EC-AE60-E4280D878F7FQ35780311-EED2B041-C26A-416C-AAA7-B2F1514C03F1Q36183209-9B24C7A2-C35B-4015-996E-37C9BDB7EE95Q36223174-A59A8FE3-C460-4442-854A-913D4777D804Q36239480-6F4DF61B-8E67-486E-A249-874719C293D2Q36530522-F4496635-73DA-40BB-8371-F2C3C94236F9Q37305512-35F56318-F7F9-4BF2-93B7-4744DEBA6CE9Q37579622-4FFE58B5-77FA-4097-9418-8C0AA57AE1EBQ37680684-0395A64B-3854-4829-BAC2-6F78EBF1D1D8Q37713193-F69291F9-B4A5-48E3-A116-F4BE08B6F0FCQ38247234-4D56F12D-887D-4F3E-9B52-4A6BA1FC2A33Q43063260-FD9F2E53-2C1E-4704-87CF-986A0877577CQ47647472-751ECA6B-FDE4-425C-9C61-6B146282FC75Q54217602-A853218D-F68F-47BD-A9BA-C2AD9AEF823C
P2860
Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhaled nitric oxide for the a ...... a randomized controlled trial.
@ast
Inhaled nitric oxide for the a ...... a randomized controlled trial.
@en
type
label
Inhaled nitric oxide for the a ...... a randomized controlled trial.
@ast
Inhaled nitric oxide for the a ...... a randomized controlled trial.
@en
prefLabel
Inhaled nitric oxide for the a ...... a randomized controlled trial.
@ast
Inhaled nitric oxide for the a ...... a randomized controlled trial.
@en
P2093
P2860
P50
P356
P1433
P1476
Inhaled nitric oxide for the a ...... a randomized controlled trial.
@en
P2093
Andrea L Conroy
Christopher Miller
James V Lavery
Kevin E Thorpe
W Conrad Liles
P2860
P2888
P356
10.1186/1745-6215-12-176
P577
2011-07-13T00:00:00Z